Humanwell Healthcare Group Co Ltd
SSE:600079

Watchlist Manager
Humanwell Healthcare Group Co Ltd Logo
Humanwell Healthcare Group Co Ltd
SSE:600079
Watchlist
Price: 22.01 CNY -0.59% Market Closed
Market Cap: 35.7B CNY
Have any thoughts about
Humanwell Healthcare Group Co Ltd?
Write Note

Humanwell Healthcare Group Co Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Humanwell Healthcare Group Co Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Humanwell Healthcare Group Co Ltd
SSE:600079
Note Receivable
ÂĄ400.9m
CAGR 3-Years
-19%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Note Receivable
ÂĄ36.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Humanwell Healthcare Group Co Ltd
Glance View

Market Cap
35.9B CNY
Industry
Pharmaceuticals

Humanwell Healthcare (Group) Co., Ltd. engages in the research and development, production, and sale of medical products. The company is headquartered in Wuhan, Hubei and currently employs 15,746 full-time employees. The Company’s products are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines and others. The firm also provides medical instruments. The firm distributes its products in both domestic market and to overseas markets.

Intrinsic Value
36.43 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Humanwell Healthcare Group Co Ltd's Note Receivable?
Note Receivable
400.9m CNY

Based on the financial report for Sep 30, 2024, Humanwell Healthcare Group Co Ltd's Note Receivable amounts to 400.9m CNY.

What is Humanwell Healthcare Group Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
-20%

Over the last year, the Note Receivable growth was -4%. The average annual Note Receivable growth rates for Humanwell Healthcare Group Co Ltd have been -19% over the past three years , -20% over the past five years .

Back to Top